Latin America White Biotech Market

Latin America White Biotech Market Analysis:

Latin America White Biotech Market is estimated to develop with a considerable CAGR throughout the foreseen period (2022 - 2027).

White biotechnology has enormous potential to transform energy production and lead to more sustainable industrial processes. It can play an important role in reducing greenhouse gases, using fossil fuels and raw materials, leading to cleaner and greener industries. The technology seems to be accepted by the public. Some non-governmental organizations (NGOs) even accept these requests due to their discreet and environmentally friendly nature. This potential is particularly valid for Latin America, with its ambitious environmental objectives and highly critical public opinion.

Recent Developments 

1. In May 2014, Kaneka made a deal with Terumo BCT Inc. to offer clinical trials in the United States with the aid of its new LDL absorption system. 
2. Belgian biotech firm UCB announced it would buy the Ra Pharmaceuticals (RARX) company for $ 2.1 billion in cash.
3. Gilead has announced plans to acquire nearly half of the anti-cancer biotech Pionyr, with an exclusive option to acquire the rest of the company as the large pharmaceutical company continues to expand into oncology. California-based Gilead said it bought a 50% stake in private company Pionyr Immunotherapeutics for $ 276 million.
4. Servier made a deal to purchase the Symphogen A/S antibody discovery biotechnology. This acquisition is likely to reinforce Servier's antibody capabilities and make sure that the early development platform from the identification of syphogens and antibodies to their full utilization.
5. Sanofi, a leading pharmacist in France agreed to purchase Belgian biotech company Ablynx for US$ 4.8 billion, beating Novo Nordisk and securing its second big deal after buying Bioverativ. The deal is another sign of accelerating mergers and acquisitions (M&A) in the global biotech sector and comes after Ablynx rejected a € 2.6 billion offer from Dane Novo Nordisk.
6. TWB and Hamilton shook hands to develop an innovative bioprocessing platform for optimization of microorganism culture.
7. White Biotech BRAIN AG recently obtained specific gene-based industrial biotech assets that belongs to MerLion Pharmaceuticals GmbH.
8. Pfizer purchased King Pharmaceuticals with US$ 3.6 billion, a high value compared to Wyeth’s acquisition. Pfizer, like Novartis, has earlier purchased Warner Lambert for about $ 89 billion.

Market Drivers and Restraints:

Rapid technological developments in all industries are an important factor that is expected to drive the target market. In addition, the government fully funds the growth of the white biotech market with an educational fund on research and development structures, as well as unification programs to produce better results, are other factors supporting growth. Among other factors, it is expected to drive the Latin American white biotech market. However, variations in manufacturing yield and organic crops everywhere, along with declining fertility of agricultural land, are among the main factors hampering the target market. Furthermore, the growing consumer demand for green compounds and chemicals is one of the other factors likely to drive the growth of the Latin America white biotech market.

Market Segmentation

Based on the products, the Latin American market is divided into biomaterials, biofuels, industrial enzymes, and biochemistry. Biofuels and biochemistry accounted for a leading portion among these. In 2017, they captured over 70% of the overall white biotech industry. Furthermore, the volatile price of conventional fuels such as natural gas, natural oil and coal has created a potential opportunity for these segments.

Based the application, the industry covers food and feed additives, bioenergy, pharmaceutical ingredients, personal care and household products. Of these, bioenergy is supposed to be a prominent application that avoids the harmful environmental effects of fossil fuels. Besides, the pharmaceutical sector highly adopts the usage of white biotechnology to create antibodies, active pharmaceutical components (APIs), and other complex biomolecules. This segment is expected to capture more than 20% share of global market revenue throughout the study period.

Impact of covid-19 on Latin America White Biotech Market

COVID-19 will continue to impact the food industry and its supply chains. Due to this uncertainty, the F&B sector experienced delays in the supply of products. Many companies have launched contingency plans to build in-depth supply chain facilities across the country. Food retailers remain committed to preserving local supplies to combat the danger of interregional transportation bans. Food manufacturers with services in other countries have begun working with local suppliers to keep products moving and overcome potential ingredient shortages. The F&B culture that had flourished over the past decades will have to see new challenges with the slowdown of the Corona virus, such as recovering from losses and a preference for ordering food online. Additionally, condensed traffic to hotels will have an understandable cascading effect on returns to the food and beverage industry, affecting the entire hotel ecosystem.

Regional Analysis

The Latin America White Biotech market has been categorized by geography into Mexico, Brazil, Peru, Chile, and the rest of the Latin America. Latin America is one of the key emerging regions, which will generate significant opportunities in the White Biotech market during the forecast period due to the growing demand for sustainable products, such as biochemicals and enzymes. The continued efforts of large corporations in developed economies, especially in Latin America, to develop various sources of clean energy to meet growing demand and reduce dependence on oil-producing countries to curb the costs of fuel imports that are supposed to improve the white biotechnology process over the outlook period.

Leading Company

Cargill Inc. had the prominent portion of the Latin America White Biotech Market in terms of sales and revenue in 2019.

Key Players

Key players in the Latin America White Biotech Market include Novozymes, Cargill Inc., BASF SE, DuPont, and Archer Daniels Midland Company